获批上市-话题@MedSci

#获批上市#

99篇内容 | 1404人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1632616, encodeId=e041163261624, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=2021年5月17日全球新冠肺炎（COVID-19）疫情简报，日新增52.1万，中国又一疫苗获批上市，全球新冠疫苗接种加速, objectType=article, longId=211433, objectId=9937211433fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9937211433fb, replyNumber=0, likeNumber=38, createdTime=2021-09-23, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9937211433fb, moduleTitle=2021年5月17日全球新冠肺炎（COVID-19）疫情简报，日新增52.1万，中国又一疫苗获批上市，全球新冠疫苗接种加速, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9937211433fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632608, encodeId=9969163260885, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=中国中医科学院院长黄璐琦院士详解抗疫“三方”获批上市, objectType=article, longId=208042, objectId=fc9f20804206, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc9f20804206, replyNumber=0, likeNumber=0, createdTime=2021-05-21, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc9f20804206, moduleTitle=中国中医科学院院长黄璐琦院士详解抗疫“三方”获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc9f20804206)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632597, encodeId=5cbc163259e72, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=齐鲁制药「马来酸阿法替尼片」获批上市, objectType=article, longId=200249, objectId=c27620024977, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c27620024977, replyNumber=0, likeNumber=35, createdTime=2021-02-26, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c27620024977, moduleTitle=齐鲁制药「马来酸阿法替尼片」获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c27620024977)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632614, encodeId=78c9163261473, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle= 基石药业再传喜讯！精准治疗药物泰吉华®获批上市，中国胃肠道间质瘤患者迎来新疗法, objectType=article, longId=209513, objectId=e01c2095131c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e01c2095131c, replyNumber=0, likeNumber=58, createdTime=2021-05-04, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e01c2095131c, moduleTitle= 基石药业再传喜讯！精准治疗药物泰吉华®获批上市，中国胃肠道间质瘤患者迎来新疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e01c2095131c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632609, encodeId=6f9216326099b, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=刚刚！康希诺与陈薇院士团队新冠疫苗获批上市, objectType=article, longId=208004, objectId=99b22080042e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99b22080042e, replyNumber=0, likeNumber=21, createdTime=2021-06-23, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99b22080042e, moduleTitle=刚刚！康希诺与陈薇院士团队新冠疫苗获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99b22080042e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632615, encodeId=02811632615a1, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=NMPA统计年报：7690家药企，创新药临床品种1096 个，生物制品 73 件，128件进口药获批上市！, objectType=article, longId=210262, objectId=a85921026208, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a85921026208, replyNumber=0, likeNumber=35, createdTime=2021-07-06, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a85921026208, moduleTitle=NMPA统计年报：7690家药企，创新药临床品种1096 个，生物制品 73 件，128件进口药获批上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a85921026208)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632605, encodeId=d0b4163260586, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=获批上市还是前功尽弃？盘点2021年上半年值得关注的10个临床实验, objectType=article, longId=206410, objectId=2c64206410bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c64206410bc, replyNumber=0, likeNumber=38, createdTime=2021-05-17, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c64206410bc, moduleTitle=获批上市还是前功尽弃？盘点2021年上半年值得关注的10个临床实验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c64206410bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632602, encodeId=57cf163260275, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=恒瑞医药PARP抑制剂获批上市, objectType=article, longId=204504, objectId=4eb920450478, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eb920450478, replyNumber=0, likeNumber=31, createdTime=2021-08-23, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eb920450478, moduleTitle=恒瑞医药PARP抑制剂获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4eb920450478)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632599, encodeId=95cd1632599d3, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=国内首款新冠抗原产品获批上市！检测时间仅需20分钟！, objectType=article, longId=203024, objectId=0cf92030248c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cf92030248c, replyNumber=0, likeNumber=33, createdTime=2021-03-26, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cf92030248c, moduleTitle=国内首款新冠抗原产品获批上市！检测时间仅需20分钟！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cf92030248c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632596, encodeId=92c81632596f0, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=第三款国产阿达木单抗注射液获批上市, objectType=article, longId=200239, objectId=18dc200239fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18dc200239fd, replyNumber=0, likeNumber=40, createdTime=2021-01-15, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18dc200239fd, moduleTitle=第三款国产阿达木单抗注射液获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18dc200239fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632598, encodeId=41fc163259804, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=阿斯利康「替格瑞洛分散片」在中国获批上市, objectType=article, longId=200250, objectId=423c200250b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=423c200250b7, replyNumber=0, likeNumber=32, createdTime=2020-09-20, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=423c200250b7, moduleTitle=阿斯利康「替格瑞洛分散片」在中国获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=423c200250b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632592, encodeId=c6cf16325924b, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=我国使用境内真实世界数据的医疗器械产品获批上市, objectType=article, longId=190986, objectId=041519098662, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=041519098662, replyNumber=0, likeNumber=34, createdTime=2020-12-10, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=041519098662, moduleTitle=我国使用境内真实世界数据的医疗器械产品获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=041519098662)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632593, encodeId=7ae516325939c, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=中国上市的适应症！罗氏VENTANA PD-L1（SP263）检测作为治疗尿路上皮癌的伴随诊断获批上市, objectType=article, longId=194187, objectId=a31b19418e54, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a31b19418e54, replyNumber=0, likeNumber=31, createdTime=2020-11-15, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a31b19418e54, moduleTitle=中国上市的适应症！罗氏VENTANA PD-L1（SP263）检测作为治疗尿路上皮癌的伴随诊断获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a31b19418e54)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632600, encodeId=de47163260055, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=2020年11月24日全球新冠肺炎（COVID-19）疫情简报，确诊超5945万，国内外疫苗近期可能陆续获批上市, objectType=article, longId=203695, objectId=24bd20369537, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24bd20369537, replyNumber=0, likeNumber=40, createdTime=2021-01-01, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24bd20369537, moduleTitle=2020年11月24日全球新冠肺炎（COVID-19）疫情简报，确诊超5945万，国内外疫苗近期可能陆续获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24bd20369537)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632601, encodeId=56b91632601c1, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=默沙东多拉韦林在中国获批上市, objectType=article, longId=203937, objectId=1ac120393ea6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ac120393ea6, replyNumber=0, likeNumber=35, createdTime=2021-05-28, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ac120393ea6, moduleTitle=默沙东多拉韦林在中国获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ac120393ea6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632588, encodeId=4a0e1632588e5, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=国产第二款慢性丙型肝炎治疗药物盐酸可洛派韦胶囊获批上市, objectType=article, longId=187927, objectId=1f1518e927fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f1518e927fe, replyNumber=0, likeNumber=37, createdTime=2020-05-01, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f1518e927fe, moduleTitle=国产第二款慢性丙型肝炎治疗药物盐酸可洛派韦胶囊获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f1518e927fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632591, encodeId=e885163259167, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=三代试管婴儿PGS获批上市，配套40万保险，开辟NIPT外的第二生育健康市场!, objectType=article, longId=190887, objectId=e48419088edd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e48419088edd, replyNumber=0, likeNumber=34, createdTime=2020-12-02, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e48419088edd, moduleTitle=三代试管婴儿PGS获批上市，配套40万保险，开辟NIPT外的第二生育健康市场!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e48419088edd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632594, encodeId=a83c163259489, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=肿瘤电场治疗在中国内地获批上市, objectType=article, longId=194224, objectId=d61d194224e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d61d194224e7, replyNumber=0, likeNumber=32, createdTime=2020-09-18, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d61d194224e7, moduleTitle=肿瘤电场治疗在中国内地获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d61d194224e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632595, encodeId=a709163259592, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=贝达药业第二代ALK靶向药物恩沙替尼有望很快获批上市, objectType=article, longId=197176, objectId=f67a19e17634, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f67a19e17634, replyNumber=0, likeNumber=25, createdTime=2020-08-05, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f67a19e17634, moduleTitle=贝达药业第二代ALK靶向药物恩沙替尼有望很快获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f67a19e17634)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1632584, encodeId=3bff16325845e, content=<a href='/topic/show?id=aa0488034a0' target=_blank style='color:#2F92EE;'>#获批上市#</a>, objectTitle=国内贝伐珠单抗生物类似药获批上市, objectType=article, longId=184478, objectId=fb2a1844e82e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb2a1844e82e, replyNumber=0, likeNumber=42, createdTime=2020-02-06, rootId=0, userName=weiz, userId=820f21933891, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb2a1844e82e, moduleTitle=国内贝伐珠单抗生物类似药获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb2a1844e82e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

获批上市

2020-05-29

weiz (审核中...)

前往app查看评论内容

#获批上市#

2021年5月17日全球新冠肺炎（COVID-19）疫情简报，日新增52.1万，中国又一疫苗获批上市，全球新冠疫苗接种加速

2021-09-23

weiz (审核中...)

前往app查看评论内容

#获批上市#

中国中医科学院院长黄璐琦院士详解抗疫“三方”获批上市

2021-05-21

weiz (审核中...)

前往app查看评论内容

#获批上市#

齐鲁制药「马来酸阿法替尼片」获批上市

2021-02-26

weiz (审核中...)

前往app查看评论内容

#获批上市#

基石药业再传喜讯！精准治疗药物泰吉华®获批上市，中国胃肠道间质瘤患者迎来新疗法

2021-05-04

weiz (审核中...)

前往app查看评论内容

#获批上市#

刚刚！康希诺与陈薇院士团队新冠疫苗获批上市

2021-06-23

weiz (审核中...)

前往app查看评论内容

#获批上市#

NMPA统计年报：7690家药企，创新药临床品种1096 个，生物制品 73 件，128件进口药获批上市！

2021-07-06

weiz (审核中...)

前往app查看评论内容

#获批上市#

获批上市还是前功尽弃？盘点2021年上半年值得关注的10个临床实验

2021-05-17

weiz (审核中...)

前往app查看评论内容

#获批上市#

恒瑞医药PARP抑制剂获批上市

2021-08-23

weiz (审核中...)

前往app查看评论内容

#获批上市#

国内首款新冠抗原产品获批上市！检测时间仅需20分钟！

2021-03-26

weiz (审核中...)

前往app查看评论内容

#获批上市#

第三款国产阿达木单抗注射液获批上市

2021-01-15

weiz (审核中...)

前往app查看评论内容

#获批上市#

阿斯利康「替格瑞洛分散片」在中国获批上市

2020-09-20

weiz (审核中...)

前往app查看评论内容

#获批上市#

我国使用境内真实世界数据的医疗器械产品获批上市

2020-12-10

weiz (审核中...)

前往app查看评论内容

#获批上市#

中国上市的适应症！罗氏VENTANA PD-L1（SP263）检测作为治疗尿路上皮癌的伴随诊断获批上市

2020-11-15

weiz (审核中...)

前往app查看评论内容

#获批上市#

2020年11月24日全球新冠肺炎（COVID-19）疫情简报，确诊超5945万，国内外疫苗近期可能陆续获批上市

2021-01-01

weiz (审核中...)

前往app查看评论内容

#获批上市#

默沙东多拉韦林在中国获批上市

2021-05-28

weiz (审核中...)

前往app查看评论内容

#获批上市#

国产第二款慢性丙型肝炎治疗药物盐酸可洛派韦胶囊获批上市

2020-05-01

weiz (审核中...)

前往app查看评论内容

#获批上市#

三代试管婴儿PGS获批上市，配套40万保险，开辟NIPT外的第二生育健康市场!

2020-12-02

智智灵药 (审核中...)

前往app查看评论内容

#获批上市#

肿瘤电场治疗在中国内地获批上市

2020-09-18

weiz (审核中...)

前往app查看评论内容

#获批上市#

贝达药业第二代ALK靶向药物恩沙替尼有望很快获批上市

2020-08-05

weiz (审核中...)

前往app查看评论内容

#获批上市#

国内贝伐珠单抗生物类似药获批上市

2020-02-06

科室
- - 订阅+
  - 更多科室
工具
服务